News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Antonio D’Alessio: Our work on neoadjuvant ICI in HCC has been chosen for the 2025 ASCO GI Merit Award
Antonio D'Alessio/X
Jan 19, 2025, 23:07

Antonio D’Alessio: Our work on neoadjuvant ICI in HCC has been chosen for the 2025 ASCO GI Merit Award

Antonio D’Alessio, Medical Oncologist and PhD student at Imperial College London, shared a post on X:

“Wonderful news – Conquer Cancer, the ASCO Foundation has chosen our work on neoadjuvant ICI in HCC for the 2025 ASCO GI Merit Award. Pathological or radiological response as best RFS predictor?

See you at my poster next Friday in San Francisco!”

Antonio D'Alessio: Our work on neoadjuvant ICI in HCC has been chosen for the 2025 ASCO GI Merit Award

Read further.

More posts featuring Antonio D’Alessio.

Antonio D'Alessio ASCO GI Merit Award cancer Conquer Cancer the ASCO Foundation HCC OncoDaily Oncology
Special Coverage
Blog
Apr 18, 2025, 20:22
Applications are open for the ESMO Research Fellowship
Blog
Apr 18, 2025, 20:12
Caitríona Duggan: Delighted for the opportunity to share our work at MASCC
Blog
Apr 18, 2025, 20:03
Fumiko Ladd Chino: Honored to be invited to speak about financial toxicity
Blog
Apr 18, 2025, 20:02
Estelamari Rodriguez: ACS NLCRT Biomarker Workshop version of brainstorming with the stars
Blog
Apr 18, 2025, 19:54
Sami Mansfield: Fiber, the microbiome, and cancer care
Blog
Apr 18, 2025, 19:49
Eric K. Singhi Discusses Lung Cancer at ASCO 2025
Science
Apr 18, 2025, 19:44
Nirmala Bhoo Pathy: The need for race and ethnicity data in cancer control
Science
Apr 18, 2025, 19:28
Andreas Charalambous: Achieving digital transformation in cancer care across Europe
Blog
Apr 18, 2025, 19:26
SIOG - Older adults deserve better: Let’s close the gap in Cancer Care
Science
Apr 18, 2025, 19:10
Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials
Blog
Apr 18, 2025, 18:58
Mission Adaptation and Mission Cancer: Resilient Health Systems for Cancer - ECHoS
Blog
Apr 18, 2025, 18:55
Robert F. Kennedy Jr. visited U.S. FDA with Commissioner Martin Makary on Medical Innovation